Loading viewer...
presentation
Format: PDF presentation
UPM's Q2 2023 presentation highlights significant market downturns, financial results, and ongoing transformation efforts amidst challenging conditions.
investor_presentation
presentation
Enanta Pharmaceuticals
presentation
Dycom Industries
presentation
Biotage AB
presentation
Falck Renewables